Rapid blood pressure reduction in acute intracerebral hemorrhage: Feasibility and safety

Sebastian Koch, Jose G. Romano, Alejandro M. Forteza, Carolina Mejia Otero, Alejandro Rabinstein

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Background: The optimal blood pressure (BP) for treating acute intracerebral hemorrhage remains (ICH) uncertain. High BP may contribute to hematoma growth while excessive BP reduction might precipitate peri-hemorrhage ischemia. We examine here the feasibility and safety of reducing BP to lower than presently recommended levels in patients with acute ICH. Methods: Patients with ICH were prospectively randomized to standard BP treatment (mean arterial BP [MAP] 110-130 mmHg) or aggressive BP lowering (MAP < 110 mmHg) within 8 h of symptom onset. MAP was managed during the 48 h treatment period. NIHSS was obtained at baseline, 24, and 48 h. Brain CT was done 24 h after symptoms. A modified Rankin Scale (mRs) was obtained at 90 days. A clinical decline (NIHSS drop ≥2 points) within the first 48 h was the primary endpoint. Hematoma enlargement at 24 h was a secondary endpoint. Results: We enrolled 21 patients into each group. Mean age was 60.6 ± 12.3 years and MAP on presentation was 147.6 ± 18.2 mmHg. Treatment was started on average 3.2 ± 2.2 h after symptom onset. Baseline clinical variables were identical between the 2 treatment groups. Target blood pressure was achieved within 87.1 ± 59.6 min in the standard group and 163.5 ± 163.8 min in the aggressive BP treatment group. There were no significant differences in early neurological deterioration, hematoma and edema growth, and clinical outcome at 90 days. Conclusion: A more aggressive reduction of acute hypertension after ICH does not increase the rate of neurological deterioration even when treatment is initiated within hours of symptom onset. Lowering BP aggressively did not affect hematoma and edema expansion but this possibility deserves further study.

Original languageEnglish (US)
Pages (from-to)316-321
Number of pages6
JournalNeurocritical Care
Volume8
Issue number3
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Cerebral Hemorrhage
Blood Pressure
Safety
Hematoma
Edema
Arterial Pressure
Therapeutics
Hypertension
Growth
Ischemia
Hemorrhage
Brain

Keywords

  • Hematoma growth
  • Hypertension
  • Intracerebral hemorrhage

ASJC Scopus subject areas

  • Clinical Neurology
  • Critical Care and Intensive Care Medicine

Cite this

Rapid blood pressure reduction in acute intracerebral hemorrhage : Feasibility and safety. / Koch, Sebastian; Romano, Jose G.; Forteza, Alejandro M.; Otero, Carolina Mejia; Rabinstein, Alejandro.

In: Neurocritical Care, Vol. 8, No. 3, 01.06.2008, p. 316-321.

Research output: Contribution to journalArticle

Koch, Sebastian ; Romano, Jose G. ; Forteza, Alejandro M. ; Otero, Carolina Mejia ; Rabinstein, Alejandro. / Rapid blood pressure reduction in acute intracerebral hemorrhage : Feasibility and safety. In: Neurocritical Care. 2008 ; Vol. 8, No. 3. pp. 316-321.
@article{34deafa5b1214571bd58deea2006e6a7,
title = "Rapid blood pressure reduction in acute intracerebral hemorrhage: Feasibility and safety",
abstract = "Background: The optimal blood pressure (BP) for treating acute intracerebral hemorrhage remains (ICH) uncertain. High BP may contribute to hematoma growth while excessive BP reduction might precipitate peri-hemorrhage ischemia. We examine here the feasibility and safety of reducing BP to lower than presently recommended levels in patients with acute ICH. Methods: Patients with ICH were prospectively randomized to standard BP treatment (mean arterial BP [MAP] 110-130 mmHg) or aggressive BP lowering (MAP < 110 mmHg) within 8 h of symptom onset. MAP was managed during the 48 h treatment period. NIHSS was obtained at baseline, 24, and 48 h. Brain CT was done 24 h after symptoms. A modified Rankin Scale (mRs) was obtained at 90 days. A clinical decline (NIHSS drop ≥2 points) within the first 48 h was the primary endpoint. Hematoma enlargement at 24 h was a secondary endpoint. Results: We enrolled 21 patients into each group. Mean age was 60.6 ± 12.3 years and MAP on presentation was 147.6 ± 18.2 mmHg. Treatment was started on average 3.2 ± 2.2 h after symptom onset. Baseline clinical variables were identical between the 2 treatment groups. Target blood pressure was achieved within 87.1 ± 59.6 min in the standard group and 163.5 ± 163.8 min in the aggressive BP treatment group. There were no significant differences in early neurological deterioration, hematoma and edema growth, and clinical outcome at 90 days. Conclusion: A more aggressive reduction of acute hypertension after ICH does not increase the rate of neurological deterioration even when treatment is initiated within hours of symptom onset. Lowering BP aggressively did not affect hematoma and edema expansion but this possibility deserves further study.",
keywords = "Hematoma growth, Hypertension, Intracerebral hemorrhage",
author = "Sebastian Koch and Romano, {Jose G.} and Forteza, {Alejandro M.} and Otero, {Carolina Mejia} and Alejandro Rabinstein",
year = "2008",
month = "6",
day = "1",
doi = "10.1007/s12028-008-9085-8",
language = "English (US)",
volume = "8",
pages = "316--321",
journal = "Neurocritical Care",
issn = "1541-6933",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Rapid blood pressure reduction in acute intracerebral hemorrhage

T2 - Feasibility and safety

AU - Koch, Sebastian

AU - Romano, Jose G.

AU - Forteza, Alejandro M.

AU - Otero, Carolina Mejia

AU - Rabinstein, Alejandro

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Background: The optimal blood pressure (BP) for treating acute intracerebral hemorrhage remains (ICH) uncertain. High BP may contribute to hematoma growth while excessive BP reduction might precipitate peri-hemorrhage ischemia. We examine here the feasibility and safety of reducing BP to lower than presently recommended levels in patients with acute ICH. Methods: Patients with ICH were prospectively randomized to standard BP treatment (mean arterial BP [MAP] 110-130 mmHg) or aggressive BP lowering (MAP < 110 mmHg) within 8 h of symptom onset. MAP was managed during the 48 h treatment period. NIHSS was obtained at baseline, 24, and 48 h. Brain CT was done 24 h after symptoms. A modified Rankin Scale (mRs) was obtained at 90 days. A clinical decline (NIHSS drop ≥2 points) within the first 48 h was the primary endpoint. Hematoma enlargement at 24 h was a secondary endpoint. Results: We enrolled 21 patients into each group. Mean age was 60.6 ± 12.3 years and MAP on presentation was 147.6 ± 18.2 mmHg. Treatment was started on average 3.2 ± 2.2 h after symptom onset. Baseline clinical variables were identical between the 2 treatment groups. Target blood pressure was achieved within 87.1 ± 59.6 min in the standard group and 163.5 ± 163.8 min in the aggressive BP treatment group. There were no significant differences in early neurological deterioration, hematoma and edema growth, and clinical outcome at 90 days. Conclusion: A more aggressive reduction of acute hypertension after ICH does not increase the rate of neurological deterioration even when treatment is initiated within hours of symptom onset. Lowering BP aggressively did not affect hematoma and edema expansion but this possibility deserves further study.

AB - Background: The optimal blood pressure (BP) for treating acute intracerebral hemorrhage remains (ICH) uncertain. High BP may contribute to hematoma growth while excessive BP reduction might precipitate peri-hemorrhage ischemia. We examine here the feasibility and safety of reducing BP to lower than presently recommended levels in patients with acute ICH. Methods: Patients with ICH were prospectively randomized to standard BP treatment (mean arterial BP [MAP] 110-130 mmHg) or aggressive BP lowering (MAP < 110 mmHg) within 8 h of symptom onset. MAP was managed during the 48 h treatment period. NIHSS was obtained at baseline, 24, and 48 h. Brain CT was done 24 h after symptoms. A modified Rankin Scale (mRs) was obtained at 90 days. A clinical decline (NIHSS drop ≥2 points) within the first 48 h was the primary endpoint. Hematoma enlargement at 24 h was a secondary endpoint. Results: We enrolled 21 patients into each group. Mean age was 60.6 ± 12.3 years and MAP on presentation was 147.6 ± 18.2 mmHg. Treatment was started on average 3.2 ± 2.2 h after symptom onset. Baseline clinical variables were identical between the 2 treatment groups. Target blood pressure was achieved within 87.1 ± 59.6 min in the standard group and 163.5 ± 163.8 min in the aggressive BP treatment group. There were no significant differences in early neurological deterioration, hematoma and edema growth, and clinical outcome at 90 days. Conclusion: A more aggressive reduction of acute hypertension after ICH does not increase the rate of neurological deterioration even when treatment is initiated within hours of symptom onset. Lowering BP aggressively did not affect hematoma and edema expansion but this possibility deserves further study.

KW - Hematoma growth

KW - Hypertension

KW - Intracerebral hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=51449098018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51449098018&partnerID=8YFLogxK

U2 - 10.1007/s12028-008-9085-8

DO - 10.1007/s12028-008-9085-8

M3 - Article

C2 - 18360781

AN - SCOPUS:51449098018

VL - 8

SP - 316

EP - 321

JO - Neurocritical Care

JF - Neurocritical Care

SN - 1541-6933

IS - 3

ER -